Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29286206

NC(=O)CC(N)C(=O)N1CCC[C@H]1C(=O)OCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 9/20 0.50
F2 P00734 1/20 0.48
DPP4 P27487 3/20 0.45
DPP8 Q6V1X1 3/20 0.45
DPP7 Q9UHL4 3/20 0.45
DPP9 Q86TI2 2/20 0.45
FAP Q12884 1/20 0.45
ACE P12821 3/20 0.45
ADORA3 P0DMS8 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA2B P29275 1/20 0.44
ADORA1 P30542 1/20 0.44
CTRB1 P17538 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7290929 0.94 FKBP1A (0.55) FKBP1ADPP4DPP8DPP7DPP9
SCHEMBL25129445 0.94 FKBP1A (0.55) FKBP1ADPP4DPP8DPP7DPP9
Hydrochloric Acid SCHEMBL7275982 0.93 FKBP1A (0.54) FKBP1ADPP4DPP8DPP7DPP9
Trifluoroacetic Acid SCHEMBL29290365 0.89 FKBP1A (0.51) FKBP1AF2DPP4DPP8DPP7
Trifluoroacetic Acid SCHEMBL28910722 0.87 FKBP1A (0.55) FKBP1AF2ACE
SCHEMBL8365666 0.85 DPP4 (0.61) FKBP1ADPP4DPP8DPP7DPP9
SCHEMBL7508784 0.85 DPP4 (0.61) FKBP1ADPP4DPP8DPP7DPP9
Hydrochloric Acid SCHEMBL10403931 0.84 DPP4 (0.60) FKBP1ADPP4DPP8DPP7DPP9
SCHEMBL38652282 0.84 FKBP1A (0.53) FKBP1ADPP4DPP8DPP7DPP9
Hydrochloric Acid SCHEMBL7327619 0.83 FKBP1A (0.55) FKBP1ADPP4DPP8DPP7DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118354796-A Compounds, pharmaceutical compositions and methods for treating, preventing or managing hyperproliferative disorders 文赛克斯制药有限责任公司 2024-07-16 CN disclosed